Home > Insider Trading > Filing (0001140361-12-041955)

Filing Details

Accession Number:: 0001140361-12-041955
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-09-28 19:46:16
Reporting Period:: 2012-09-26

Filing Date:: 2012-09-28
Accepted Time:: 2012-09-28 18:46:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1323974	Mwi Veterinary Supply Inc.	MWIV	Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)	020620757

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1334044	Jr N Robert Rebholtz	3041 W. Pasadena Dr. Boise ID 83705		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.01 Per Share	Disposition	2012-09-26	1,340	$107.97	32,500	No	4	S	Direct
Common Stock, Par Value $0.01 Per Share	Disposition	2012-09-26	1,201	$106.02	154,846	No	4	S	Indirect	See footnote
Common Stock, Par Value $0.01 Per Share	Disposition	2012-09-26	911	$107.16	153,935	No	4	S	Indirect	See footnote
Common Stock, Par Value $0.01 Per Share	Disposition	2012-09-26	1,048	$108.12	152,887	No	4	S	Indirect	See footnote
Common Stock, Par Value $0.01 Per Share	Disposition	2012-09-27	1,300	$106.03	151,587	No	4	S	Indirect	See footnote
Common Stock, Par Value $0.01 Per Share	Disposition	2012-09-27	1,401	$107.07	150,186	No	4	S	Indirect	See footnote
Common Stock, Par Value $0.01 Per Share	Disposition	2012-09-27	1,000	$107.90	149,186	No	4	S	Indirect	See footnote
Common Stock, Par Value $0.01 Per Share	Disposition	2012-09-28	2,266	$106.98	146,920	No	4	S	Indirect	See footnote
Common Stock, Par Value $0.01 Per Share	Disposition	2012-09-28	441	$107.76	146,479	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Robert N. Rebholtz Jr. on September 6, 2012.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by The Rebholtz Descendants Trust on September 8, 2012.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $107.54 to $108.26, inclusive. Mr. Rebholtz has provided to the Company and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $105.775 to $106.65, inclusive. Mr. Rebholtz has provided to the Company and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $106.79 to $107.60, inclusive. Mr. Rebholtz has provided to the Company and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $107.89 to $108.34, inclusive. Mr. Rebholtz has provided to the Company and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $105.34 to $106.305, inclusive. Mr. Rebholtz has provided to the Company and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $106.36 to $107.27, inclusive. Mr. Rebholtz has provided to the Company and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $107.59 to $108.16, inclusive. Mr. Rebholtz has provided to the Company and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $106.71 to $107.68, inclusive. Mr. Rebholtz has provided to the Company and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $107.71 to $107.94, inclusive. Mr. Rebholtz has provided to the Company and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Held by The Rebholtz Descendants' Trust for the benefit of Mr. Rebholtz's family and certain other persons. Mr. Rebholtz expressly disclaims beneficial ownership of any shares held by such trust that exceed his pecuniary interest therein.